N-[3-(difluoromethyl)-1-[4-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]cyclohexyl]pyrazol-4-yl]-1,5-naphthyridine-4-carboxamide

C39H44F2N10O4 — CID 156823535

IUPACN-[3-(difluoromethyl)-1-[4-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]cyclohexyl]pyrazol-4-yl]-1,5-naphthyridine-4-carboxamide
SMILESCN(CC1CCC(n2cc(NC(=O)c3ccnc4cccnc34)c(C(F)F)n2)CC1)C1CCN(c2cccc3c2n(C)c(=O)n3C2CCC(=O)NC2=O)CC1
InChIInChI=1S/C39H44F2N10O4/c1-47(24-15-19-49(20-16-24)29-6-3-7-30-35(29)48(2)39(55)51(30)31-12-13-32(52)45-38(31)54)21-23-8-10-25(11-9-23)50-22-28(34(46-50)36(40)41)44-37(53)26-14-18-42-27-5-4-17-43-33(26)27/h3-7,14,17-18,22-25,31,36H,8-13,15-16,19-21H2,1-2H3,(H,44,53)(H,45,52,54)
InChIKeySUDZUEVQXXDWCM-UHFFFAOYSA-N
MW754.84 g/mol
LogP4.98
Rot. Bonds9

About N-[3-(difluoromethyl)-1-[4-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]cyclohexyl]pyrazol-4-yl]-1,5-naphthyridine-4-carboxamide

N-[3-(difluoromethyl)-1-[4-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]cyclohexyl]pyrazol-4-yl]-1,5-naphthyridine-4-carboxamide (PubChem CID 156823535) has the molecular formula C39H44F2N10O4 and a molecular weight of 754.84 g/mol. Its IUPAC name is N-[3-(difluoromethyl)-1-[4-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]cyclohexyl]pyrazol-4-yl]-1,5-naphthyridine-4-carboxamide.

Molecular Properties

Compound NameN-[3-(difluoromethyl)-1-[4-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]cyclohexyl]pyrazol-4-yl]-1,5-naphthyridine-4-carboxamide
PubChem CID156823535
Molecular FormulaC39H44F2N10O4
Molecular Weight754.84 g/mol
Exact Mass754.35
IUPAC NameN-[3-(difluoromethyl)-1-[4-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]cyclohexyl]pyrazol-4-yl]-1,5-naphthyridine-4-carboxamide
SMILESCN(CC1CCC(n2cc(NC(=O)c3ccnc4cccnc34)c(C(F)F)n2)CC1)C1CCN(c2cccc3c2n(C)c(=O)n3C2CCC(=O)NC2=O)CC1
InChIInChI=1S/C39H44F2N10O4/c1-47(24-15-19-49(20-16-24)29-6-3-7-30-35(29)48(2)39(55)51(30)31-12-13-32(52)45-38(31)54)21-23-8-10-25(11-9-23)50-22-28(34(46-50)36(40)41)44-37(53)26-14-18-42-27-5-4-17-43-33(26)27/h3-7,14,17-18,22-25,31,36H,8-13,15-16,19-21H2,1-2H3,(H,44,53)(H,45,52,54)
InChIKeySUDZUEVQXXDWCM-UHFFFAOYSA-N
XLogP4.98
TPSA152.28 Ų
H-Bond Donors2
H-Bond Acceptors12
Rotatable Bonds9
Heavy Atoms55
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500754.84
LogP ≤ 54.98
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze N-[3-(difluoromethyl)-1-[4-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]cyclohexyl]pyrazol-4-yl]-1,5-naphthyridine-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[3-(difluoromethyl)-1-[4-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]cyclohexyl]pyrazol-4-yl]-1,5-naphthyridine-4-carboxamide?
The IUPAC name of N-[3-(difluoromethyl)-1-[4-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]cyclohexyl]pyrazol-4-yl]-1,5-naphthyridine-4-carboxamide (CID 156823535) is N-[3-(difluoromethyl)-1-[4-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]cyclohexyl]pyrazol-4-yl]-1,5-naphthyridine-4-carboxamide.
What is the SMILES notation for N-[3-(difluoromethyl)-1-[4-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]cyclohexyl]pyrazol-4-yl]-1,5-naphthyridine-4-carboxamide?
The canonical SMILES for N-[3-(difluoromethyl)-1-[4-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]cyclohexyl]pyrazol-4-yl]-1,5-naphthyridine-4-carboxamide is CN(CC1CCC(n2cc(NC(=O)c3ccnc4cccnc34)c(C(F)F)n2)CC1)C1CCN(c2cccc3c2n(C)c(=O)n3C2CCC(=O)NC2=O)CC1.
What is the InChIKey of N-[3-(difluoromethyl)-1-[4-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]cyclohexyl]pyrazol-4-yl]-1,5-naphthyridine-4-carboxamide?
The InChIKey is SUDZUEVQXXDWCM-UHFFFAOYSA-N. The full InChI is InChI=1S/C39H44F2N10O4/c1-47(24-15-19-49(20-16-24)29-6-3-7-30-35(29)48(2)39(55)51(30)31-12-13-32(52)45-38(31)54)21-23-8-10-25(11-9-23)50-22-28(34(46-50)36(40)41)44-37(53)26-14-18-42-27-5-4-17-43-33(26)27/h3-7,14,17-18,22-25,31,36H,8-13,15-16,19-21H2,1-2H3,(H,44,53)(H,45,52,54).
What are the key properties of N-[3-(difluoromethyl)-1-[4-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]cyclohexyl]pyrazol-4-yl]-1,5-naphthyridine-4-carboxamide?
N-[3-(difluoromethyl)-1-[4-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]cyclohexyl]pyrazol-4-yl]-1,5-naphthyridine-4-carboxamide has a molecular weight of 754.84 g/mol, XLogP of 4.98, 9 rotatable bonds, 2 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-(difluoromethyl)-1-[4-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]cyclohexyl]pyrazol-4-yl]-1,5-naphthyridine-4-carboxamide is sourced from PubChem (CID 156823535), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).